Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenium | 3 | 2022 | 150 | 1.960 |
Why?
|
| Myocytes, Cardiac | 6 | 2025 | 173 | 1.220 |
Why?
|
| Selenomethionine | 1 | 2025 | 13 | 0.940 |
Why?
|
| Fructose | 1 | 2025 | 23 | 0.930 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2021 | 51 | 0.910 |
Why?
|
| Lyases | 1 | 2025 | 45 | 0.890 |
Why?
|
| Sepsis | 2 | 2022 | 90 | 0.870 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2022 | 11 | 0.870 |
Why?
|
| Membrane Glycoproteins | 2 | 2022 | 221 | 0.780 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2021 | 11 | 0.730 |
Why?
|
| Cardiovascular System | 1 | 2021 | 37 | 0.700 |
Why?
|
| Calcification, Physiologic | 1 | 2021 | 18 | 0.700 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 63 | 0.700 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 729 | 0.690 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2021 | 47 | 0.680 |
Why?
|
| Calcium Signaling | 1 | 2021 | 108 | 0.650 |
Why?
|
| Coronary Vessels | 1 | 2020 | 92 | 0.640 |
Why?
|
| Myocardium | 5 | 2025 | 251 | 0.640 |
Why?
|
| Immunity, Innate | 1 | 2020 | 168 | 0.620 |
Why?
|
| Heart | 1 | 2021 | 181 | 0.620 |
Why?
|
| Diet | 1 | 2025 | 810 | 0.610 |
Why?
|
| MicroRNAs | 2 | 2022 | 501 | 0.570 |
Why?
|
| Mice | 9 | 2025 | 6490 | 0.510 |
Why?
|
| Mice, Knockout | 4 | 2025 | 1010 | 0.500 |
Why?
|
| Selenoproteins | 3 | 2022 | 146 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 1804 | 0.460 |
Why?
|
| Animals | 14 | 2025 | 16695 | 0.430 |
Why?
|
| Selenocysteine | 2 | 2024 | 54 | 0.410 |
Why?
|
| Neoplasms | 1 | 2022 | 1341 | 0.360 |
Why?
|
| Pyruvate Kinase | 1 | 2025 | 18 | 0.230 |
Why?
|
| Energy Metabolism | 2 | 2025 | 181 | 0.230 |
Why?
|
| Peroxiredoxin VI | 1 | 2024 | 3 | 0.230 |
Why?
|
| Male | 7 | 2025 | 22779 | 0.220 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 140 | 0.220 |
Why?
|
| Heart Injuries | 1 | 2023 | 10 | 0.210 |
Why?
|
| Reperfusion Injury | 1 | 2023 | 57 | 0.200 |
Why?
|
| Rats | 2 | 2021 | 3701 | 0.200 |
Why?
|
| Thermogenesis | 1 | 2022 | 24 | 0.190 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2022 | 5 | 0.190 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 39 | 0.190 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 21 | 0.190 |
Why?
|
| Adipocytes | 1 | 2022 | 58 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 56 | 0.180 |
Why?
|
| 5'-Nucleotidase | 1 | 2021 | 6 | 0.180 |
Why?
|
| Joint Diseases | 1 | 2021 | 5 | 0.180 |
Why?
|
| Diphosphates | 1 | 2021 | 6 | 0.180 |
Why?
|
| Pyrophosphatases | 1 | 2021 | 8 | 0.180 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2021 | 19 | 0.180 |
Why?
|
| Pseudomonas syringae | 2 | 2011 | 11 | 0.180 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2021 | 7 | 0.180 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 71 | 0.180 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 112 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 101 | 0.170 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2021 | 32 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2021 | 33 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2022 | 324 | 0.170 |
Why?
|
| Surface-Active Agents | 2 | 2011 | 44 | 0.170 |
Why?
|
| Proteome | 1 | 2022 | 150 | 0.170 |
Why?
|
| Calcinosis | 1 | 2021 | 61 | 0.170 |
Why?
|
| Humans | 9 | 2024 | 42163 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 83 | 0.170 |
Why?
|
| Dietary Supplements | 1 | 2021 | 208 | 0.160 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 11 | 0.160 |
Why?
|
| Animals, Newborn | 1 | 2020 | 350 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2025 | 990 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2020 | 1617 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 235 | 0.150 |
Why?
|
| Cell Survival | 2 | 2019 | 934 | 0.150 |
Why?
|
| Mitochondria | 1 | 2022 | 516 | 0.140 |
Why?
|
| Cytokines | 1 | 2020 | 661 | 0.130 |
Why?
|
| Macrophages | 1 | 2020 | 515 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2017 | 110 | 0.120 |
Why?
|
| Iron | 1 | 2017 | 247 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1737 | 0.120 |
Why?
|
| Cell Death | 3 | 2023 | 277 | 0.120 |
Why?
|
| Locomotion | 2 | 2011 | 104 | 0.110 |
Why?
|
| Flagella | 1 | 2011 | 31 | 0.090 |
Why?
|
| Oils | 1 | 2010 | 6 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 72 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 744 | 0.080 |
Why?
|
| Female | 2 | 2025 | 24018 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2019 | 2111 | 0.070 |
Why?
|
| Obesity | 1 | 2015 | 1131 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2006 | 92 | 0.060 |
Why?
|
| Gene Expression | 2 | 2006 | 692 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 223 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 658 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2024 | 134 | 0.050 |
Why?
|
| Cicatrix | 1 | 2023 | 17 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 49 | 0.050 |
Why?
|
| Genes, Insect | 1 | 2002 | 27 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 2 | 2011 | 35 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 189 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 330 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 234 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2019 | 62 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2019 | 154 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 193 | 0.040 |
Why?
|
| Transfection | 1 | 2019 | 526 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2017 | 8 | 0.030 |
Why?
|
| Cyclohexylamines | 1 | 2017 | 12 | 0.030 |
Why?
|
| Carbolines | 1 | 2017 | 17 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2598 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2017 | 62 | 0.030 |
Why?
|
| Piperazines | 1 | 2017 | 117 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1416 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 8 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 46 | 0.030 |
Why?
|
| Necrosis | 1 | 2015 | 54 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 41 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 518 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 58 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 111 | 0.030 |
Why?
|
| Weight Gain | 1 | 2015 | 138 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 138 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 310 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2015 | 199 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 683 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 242 | 0.020 |
Why?
|
| Flagellin | 1 | 2011 | 18 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 168 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2011 | 168 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 279 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1848 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 50 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2010 | 92 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 105 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1554 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 599 | 0.020 |
Why?
|
| Exons | 1 | 2006 | 91 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 649 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 508 | 0.010 |
Why?
|
| Photoperiod | 1 | 2002 | 27 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2002 | 37 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 183 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 1169 | 0.010 |
Why?
|